[An economic evaluation of measles vaccination in District 3 of the city of Bucharest].
The cost-profit analysis (CPA) of the anti-measles (AM) vaccination, 10 years after its introduction in the anti-epidemic strategy, shows that in the district 3 of Bucharest, the prevention, by vaccination, of more than 17,000 cases of getting ill was associated with a net profit of 11 X 10(6) lei, and a profit/cost ratio (PCr) of 6/1. These figures evidence the economic value of the AM vaccination and stimulate the further development of the programme for the control of measles by vaccination.
Ion-Nedelcu
N
N
Mihăileanu
C
C
Dobrescu
A
A
D003362:Cost-Benefit Analysis; D006801:Humans; D008457:Measles / Q000191:economics* / Q000453:epidemiology / Q000517:prevention & control; D008458:Measles Vaccine / Q000008:administration & dosage*; D012383:Romania; D014505:Urban Population
D008458:Measles Vaccine
Evaluarea economică a vaccinării antirujeolice in sectorul 3 al Municipiului Bucureşti.